Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature

Filippo Gavi, Paolo Emilio Santoro, Carlotta Amantea*, Pierluigi Russo, Filippo Marino, Ivan Borrelli, Umberto Moscato, Nazario Foschi

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Background: The aim of this paper is to discuss the impact of COVID-19 on patients with urological malignancies (prostate cancer, bladder and upper tract urothelial cancer, kidney cancer, penile and testicular cancer) and to review the available recommendations reported in the literature. Methods: A review was performed, through the PubMed database, regarding available recommendations reported in the literature, to identify studies examining the impact of COVID-19 on treatment and clinical outcomes (including upstaging, recurrence, and mortality) for uro-oncological patients. Results: The COVID-19 pandemic dramatically changed the urological guidelines and patients’ access to screening programs and follow-up visits. Great efforts were undertaken to guarantee treatments to high-risk patients although follow up was not always possible due to recurrent surges, and patients with lower risk cancers had to wait for therapies. Conclusions: Physically and mentally, uro-oncological patients paid a heavy price during the COVID-19 pandemic. Long term data on the “costs” of clinical decisions made during the COVID-19 pandemic are still to be revealed and analyzed.
Lingua originaleEnglish
pagine (da-a)176-N/A
RivistaMicroorganisms
Volume11
DOI
Stato di pubblicazionePubblicato - 2023

Keywords

  • COVID-19
  • cancer
  • review
  • uro-oncology

Fingerprint

Entra nei temi di ricerca di 'Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature'. Insieme formano una fingerprint unica.

Cita questo